NXEN — Nexien Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $0.69m
- $0.96m
Annual cashflow statement for Nexien Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.67 | -1.86 | -0.626 | -0.362 | -0.239 |
| Non-Cash Items | 2.49 | 1.76 | 0.537 | 0.277 | 0.137 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.036 | 0.007 | 0.014 | 0.003 | 0.038 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.148 | -0.091 | -0.075 | -0.082 | -0.064 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0 | 0 | — | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | — | 0 |
| Financing Cash Flow Items | — | 0.02 | 0.025 | 0 | 0.013 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.012 | 0.098 | 0.174 | 0 | 0.033 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.136 | 0.007 | 0.099 | -0.082 | -0.031 |